| Literature DB >> 36065285 |
Peini Cheng1, Kui Dong2, Zhiming Kang2, Jing Li2, Wenjuan Wang2, Xiaodan Zhang2, Guohong Zhou2.
Abstract
Infectious endophthalmitis is an important cause of vision loss worldwide. It is an inflammatory reaction caused by bacteria, fungi, and other micro-organisms and often occurs as a complication of intraocular surgery, especially following cataract surgery or intravitreal injection. The focus of the prevention and treatment of infectious endophthalmitis is the early detection of microbial flora, such as fungi or bacteria. Current identification methods for bacteria include Gram staining-based, culture-based, and polymerase chain reaction (PCR)-based methods. The matrix-assisted laser desorption/ionization time-of-flight mass spectrometry technology is now the standard identification method of bacteria and fungi after their isolation in culture. The remarkable sensitivity of PCR technology for the direct detection of micro-organisms in clinical samples makes it particularly useful in culture-positive and culture-negative endophthalmitis. Furthermore, PCR increases the rate of microorganism detection in intraocular samples by 20% and can provide a microbiology diagnosis in approximately 44.7-100% of the culture-negative cases. This review aims to introduce the development of different methods for the detection and identification of micro-organisms causing endophthalmitis through a literature review; introduce the research status of the first, second, and third-generation sequencing technologies in infectious endophthalmitis; and understand the research status of endophthalmitis microbial flora. For slow-growing and rare micro-organisms, high-throughput sequencing (HTS) offers advantages over conventional methods and provides a basis for the identification of pathogens in endophthalmitis cases with negative culture. It is a reliable platform for the identification of pathogenic bacteria of infectious endophthalmitis in the future and provides a reference for the clinical diagnosis and treatment of infectious endophthalmitis. The application of HTS technology may also be transformative for clinical microbiology and represents an exciting future direction for the epidemiology of ocular infections.Entities:
Year: 2022 PMID: 36065285 PMCID: PMC9440830 DOI: 10.1155/2022/4024260
Source DB: PubMed Journal: J Ophthalmol ISSN: 2090-004X Impact factor: 1.974
Figure 1Development of sequencing technology and application in identifying the pathogens in endophthalmitis.
Sequencing studies related to infectious endophthalmitis.
| Author | Sequencing platform | N | PTE/POE/EE | References |
|---|---|---|---|---|
| Dhanshree et al. | IlluminaHiSeq2500 | 75 | 39/28/8 | [ |
| Dhanshree et al. | IlluminaHiSeq2500 | 34 | 21/7/2 | [ |
| Appavu et al. | Applied Biosystems | 88 | 9/67/12 | [ |
| Yang Baoxia et al. | Illumina HiSeq 300 | 5 | 1/4/0 | [ |
| Philipp et al. | Illumina MiSeq | 14 | 0/14/0 | [ |
| Cecilia et al. | SMART | 50 | 0/50/0 | [ |
| Tsutomu et al. | Applied Biosystems | 3 | 0/1/2 | [ |
PTE: post-traumatic endophthalmitis; POE: postoperative endophthalmitis; EE: endogenous endophthalmitis.
Comparison of culture with HTS sequencing results.
| Sequencing platform | Positive rate of sequencing | Positive rate of culture | The most abundant genus of sequencing | Dominant bacteria of culture | References |
|---|---|---|---|---|---|
| IlluminaHiSeq2500 | 60/75 | 18/75 | Streptococcus, Staphylococcus | Streptococcus, Staphylococcus | [ |
| IlluminaHiSeq2500 | 30/34 | 15/34 | Streptococcus | Streptococcus | [ |
| Applied Biosystems | 30/88 | 20/88 |
|
| [ |
| Illumina HiSeq 300 | 5/5 | 0/5 |
|
| [ |
| Illumina MiSeq | 12/14 | 12/14 |
|
| [ |
|
|
| ||||
| SMART | 42/46 | 24/50 | Staphylococcus | Coagulase-negative Staphylococcus | [ |
| Applied Biosystems | 3/3 | 3/3 | Case 1 | Case 1 | [ |
| Case 2 | Case 2 | ||||
| Case 3 | Case 3 |
SMART: single molecule real-time sequencing.